These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease. Yang J; Wise L; Fukuchi KI Front Immunol; 2020; 11():724. PubMed ID: 32391019 [TBL] [Abstract][Full Text] [Related]
8. The effect of amyloid on microglia-neuron interactions before plaque onset occurs independently of TREM2 in a mouse model of Alzheimer's disease. von Saucken VE; Jay TR; Landreth GE Neurobiol Dis; 2020 Nov; 145():105072. PubMed ID: 32890775 [TBL] [Abstract][Full Text] [Related]
9. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease. Bivona G; Iemmolo M; Ghersi G Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175935 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological targeting of microglia dynamics in Alzheimer's disease: Preclinical and clinical evidence. Yousefizadeh A; Piccioni G; Saidi A; Triaca V; Mango D; Nisticò R Pharmacol Res; 2022 Oct; 184():106404. PubMed ID: 35988869 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease. Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051 [TBL] [Abstract][Full Text] [Related]
12. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice. Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699 [TBL] [Abstract][Full Text] [Related]
13. Glial cells in Alzheimer's disease: From neuropathological changes to therapeutic implications. Uddin MS; Lim LW Ageing Res Rev; 2022 Jun; 78():101622. PubMed ID: 35427810 [TBL] [Abstract][Full Text] [Related]
14. Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease. Wang Z; Weaver DF Int Immunopharmacol; 2022 Sep; 110():109070. PubMed ID: 35978514 [TBL] [Abstract][Full Text] [Related]
15. Environmental Enrichment Potently Prevents Microglia-Mediated Neuroinflammation by Human Amyloid β-Protein Oligomers. Xu H; Gelyana E; Rajsombath M; Yang T; Li S; Selkoe D J Neurosci; 2016 Aug; 36(35):9041-56. PubMed ID: 27581448 [TBL] [Abstract][Full Text] [Related]
16. The relationship between the morphological subtypes of microglia and Alzheimer's disease neuropathology. Paasila PJ; Davies DS; Kril JJ; Goldsbury C; Sutherland GT Brain Pathol; 2019 Nov; 29(6):726-740. PubMed ID: 30803086 [TBL] [Abstract][Full Text] [Related]